Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

NOPRODRPG0002: NOPRODRPG0002 - IRD_RPGR Patient Registry

NCT05957276 is registered in ClinicalTrials.gov with Janssen Research & Development, LLC as lead sponsor.

NCT NCT05957276
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05957276 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
NOPRODRPG0002: NOPRODRPG0002 - IRD_RPGR Patient Registry
Lead sponsor
Janssen Research & Development, LLC
Phase
Observational
Overall status
Completed
Start date
August 31, 2023
Completion date
July 2, 2026
Enrollment
886 (actual)
Sites
75

Conditions

As the registry lists them; a condition with its own page is linked.

inherited retinal diseases